After hours
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Award
Reported value range
Not reported

Glavine Paul Chief Growth Officer

Transaction date Sep 30, 2026
Public filing date Oct 1, 2026
Filing lag Filed 1 day later

HELP daily price context

Close on/before transaction
$12.29 Sep 30, 2026
First close after public filing
$11.7 Oct 2, 2026
30-day return after filing
-24.79% Through Nov 2, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Shares
Quantity / price
248,000 shares
SEC ownership
Direct
Transaction code
A
Form
4
Filing identifier
0000912282-26-001332
Filing cohort

Transactions in this filing

Showing 1 of 1
Trades
1
Issuers
1
Estimated value
Not reported
Buys / sales
0 / 0
Transactions reported in the same official filing
Issuer Transaction Traded Value
Helus Pharma Inc. HELP Current Award Sep 30, 2026 Not reported